Plaintiffs reach $2M settlement with Unilever in Antiperspirant litigation
On March 7, 2024, An Illinois Federal Court granted preliminary approval of a class wide settlement in a class action case against Unilever United States Inc. The case is titled Barnes et al. v. Unilever United States Inc., case number 1:21-cv-06191, currently in the U.S. District Court for the Northern District of Illinois.
On January 20, 2022, Shub & Johns LLC filed a complaint against Unilever after reports indicated that Unilever’s Suave antiperspirant products allegedly contained excessive levels of the carcinogen benzene. The suit further alleged that Unilever did not comply with good manufacturing practices established by the U.S. Food and Drug Administration and had potentially sold tainted products to consumers, in violation of both federal law and the Illinois Food, Drug and Cosmetic Act.
On March 25, 2022, Plaintiffs filed a Consolidated Amended Complaint after the Illinois Court consolidated all matters against Unilever concerning the allegedly adulterated antiperspirant products. On June 1, 2023, Jonathan Shub was appointed as Interim Co-Lead Counsel in the class action case.
Almost 2 years after bringing this action, Plaintiffs filed a motion for preliminary approval of a settlement that would establish a $2 Million common fund, allowing affected class members who purchased potentially contaminated Suave Antiperspirant products to submit a claim for potential reimbursement.
Click here to visit the settlement site to review more information about the litigation and settlement process. Did you purchase Suave Antiperspirant product? You may be able to submit a claim. Fill out the attached form to contact Shub & Johns for more information.
